DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota

Accumulative studies suggest that inflammatory bowel disease (IBD) may cause multiple central nervous system (CNS) pathologies. Studies have found that indoleamine-2,3-dioxygenase (IDO, rate-limiting enzyme of the kynurenine (Kyn) pathway) deficient mice were protected from endotoxin induced cognitive impairment, and Kyn administration induced cognitive memory deficits in both control and IDO-deficient mice. However, there is no investigation of the brain Kyn pathway in IBD, thus we investigated whether dextran sulfate sodium (DSS)-induced colitis could cause dysregulation of Kyn pathway in brain, and also in serum. C57BL/6J mice were given drinking water with 2% DSS for 10 consecutive days to induce colitis. In serum, we found significant increase in Kyn and kynurenic acid (Kyna) level, which was regulated by IDO-1 and KAT2 (rate-limiting enzymes of Trp-Kyn-Kyna pathway). Similarly, by analyzing GEO datasets, higher IDO-1 levels in peripheral blood monocytes and colon of UC patients was found. Furthermore, the Kyn pathway was significantly upregulated in the cerebral cortex under the action of IDO-1 after DSS treatment, which ultimately induced the neurotoxic phenotype of astrocytes. To investigate whether gut microbiota is involved in IBD-induced Kyn pathway dysregulation, we performed intestinal flora 16S rRNA sequencing and found that DSS-induced colitis significantly altered the composition and diversity of the gut microbiota. Metabolic function analysis also showed that Tryptophan metabolism, NOD-like receptor signaling pathway and MAPK signaling pathway were significantly up-regulated in the 2% DSS group. A significant association between intestinal flora and Trp metabolism (both in serum and brain) was found by correlation analysis. Overall, this study revealed that DSS-induced colitis causes dysregulation of the Kyn pathway in serum and brain by affecting rate-limiting enzymes and intestinal flora.

[1]  Jiachao Zhang,et al.  Lactobacillus plantarum HNU082 alleviates dextran sulfate sodium-induced ulcerative colitis in mice through regulating gut microbiome. , 2022, Food & function.

[2]  Yutang Wang,et al.  Sesamol ameliorates dextran sulfate sodium-induced depression-like and anxiety-like behaviors in colitis mice: the potential involvement of the gut-brain axis. , 2022, Food & function.

[3]  Kuan-Hung Lu,et al.  Saccharina japonica Ethanol Extract Ameliorates Depression/Anxiety-Like Behavior by Inhibiting Inflammation, Oxidative Stress, and Apoptosis in Dextran Sodium Sulfate Induced Ulcerative Colitis Mice , 2021, Frontiers in Nutrition.

[4]  Zhenyang Gu,et al.  Akkermansia muciniphila and its outer protein Amuc_1100 regulates tryptophan metabolism in colitis. , 2021, Food & function.

[5]  M. Oh,et al.  Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice , 2021, Brain, Behavior, and Immunity.

[6]  Haiqing Zheng,et al.  Chronic colitis exacerbates NLRP3-dependent neuroinflammation and cognitive impairment in middle-aged brain , 2021, Journal of neuroinflammation.

[7]  S. de Lusignan,et al.  Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study , 2021, Evidence-Based Mental Health.

[8]  A. Kuhad,et al.  IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson's disease. , 2021, Neurotoxicology.

[9]  Jun Wang,et al.  Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain , 2021, Gut microbes.

[10]  Sicen Wang,et al.  Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. , 2020, Pharmacological research.

[11]  Jie Song,et al.  Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. , 2020, International journal of biological macromolecules.

[12]  Lu Zhang,et al.  Qingchang Huashi Formula Attenuates DSS-Induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function. , 2020, Journal of ethnopharmacology.

[13]  Ming Lu,et al.  Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression , 2020, Brain, Behavior, and Immunity.

[14]  H. Sokol,et al.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[15]  C. Jeon,et al.  Gut microorganisms and their metabolites modulate the severity of acute colitis in a tryptophan metabolism-dependent manner , 2020, European Journal of Nutrition.

[16]  K. Karalis,et al.  Hippocampal neural stem cells and microglia response to experimental inflammatory bowel disease (IBD) , 2020, Molecular Psychiatry.

[17]  C. Mu,et al.  Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain. , 2019, Advances in nutrition.

[18]  K. Tan-No,et al.  Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain–gut axis , 2019, Journal of Neuroinflammation.

[19]  M. Colado,et al.  Changes in brain kynurenine levels via gut microbiota and gut‐barrier disruption induced by chronic ethanol exposure in mice , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Jianming Guo,et al.  Flos Abelmoschus manihot extract attenuates DSS-induced colitis by regulating gut microbiota and Th17/Treg balance. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  Huijue Jia,et al.  Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice , 2019, Molecular Psychiatry.

[22]  Xinmin Liu,et al.  LC-MS/MS-based quantification of tryptophan metabolites and neurotransmitters in the serum and brain of mice. , 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  U. Röhrig,et al.  Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond , 2019, Nature Reviews Drug Discovery.

[24]  K. Papadakis,et al.  Mechanisms of Disease: Inflammatory Bowel Diseases. , 2019, Mayo Clinic proceedings.

[25]  Ying Xie,et al.  Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota , 2018, Pharmacological research.

[26]  T. Zhao,et al.  Cortical Inflammation is Increased in a DSS-Induced Colitis Mouse Model , 2018, Neuroscience Bulletin.

[27]  J. O'Connor,et al.  Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation , 2018, Psychoneuroendocrinology.

[28]  Guangji Wang,et al.  Regulation of proinflammatory monocyte activation by the kynurenine–AhR axis underlies immunometabolic control of depressive behavior in mice , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  L. Albenberg,et al.  Gut microbiota and IBD: causation or correlation? , 2017, Nature Reviews Gastroenterology &Hepatology.

[30]  K. Berer,et al.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice , 2017, Proceedings of the National Academy of Sciences.

[31]  D. Artis,et al.  Regulation of inflammation by microbiota interactions with the host , 2017, Nature Immunology.

[32]  Ying Xie,et al.  Patchouli alcohol ameliorates dextran sodium sulfate‐induced experimental colitis and suppresses tryptophan catabolism , 2017, Pharmacological research.

[33]  T. Zisman,et al.  The microbiota in inflammatory bowel disease: current and therapeutic insights , 2017, Journal of inflammation research.

[34]  Yang Li,et al.  Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism , 2017, The FEBS journal.

[35]  Rob Knight,et al.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.

[36]  J. Carrero,et al.  Germ-free and Antibiotic-treated Mice are Highly Susceptible to Epithelial Injury in DSS Colitis. , 2016, Journal of Crohn's & colitis.

[37]  J. O'Connor,et al.  Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory , 2015, Brain, Behavior, and Immunity.

[38]  Cheng-Li Lin,et al.  A population-based cohort study. , 2015 .

[39]  Andrew H. Van Benschoten,et al.  Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. , 2014, Cell host & microbe.

[40]  F. He,et al.  The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling , 2014, Proceedings of the National Academy of Sciences.

[41]  A. De Luca,et al.  Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. , 2013, Immunity.

[42]  Gilles J. Guillemin,et al.  Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain , 2013, PloS one.

[43]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[44]  E. Marcotte,et al.  Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.

[45]  W. Khan,et al.  Investigating intestinal inflammation in DSS-induced model of IBD. , 2012, Journal of visualized experiments : JoVE.

[46]  George Perry,et al.  Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease , 2010, Redox report : communications in free radical research.

[47]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[48]  D. Männel,et al.  Blocking lymphotoxin‐β receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule‐1 (MAdCAM‐1) expression and leucocyte margination in chronic DSS‐induced colitis , 2004 .

[49]  A. Sherman,et al.  l-Kynurenine Its synthesis and possible regulatory function in brain , 1980, Neurochemical Research.

[50]  T. Yao.  [Inflammatory bowel diseases]. , 2002, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[51]  R. Schwarcz,et al.  Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism , 1991, Journal of neurochemistry.